Mineralys Therapeutics, Inc. · NASDAQ:MLYS

Srinivas Akkaraju reported a 8.20% stake in Mineralys Therapeutics, Inc. (Schedule 13D/A)

Event Sep 4, 2025 · Filed Sep 8, 2025

Srinivas Akkaraju reported a 8.20% stake in Mineralys Therapeutics, Inc., 6,346,194 shares, with active intent on Sep 4, 2025. Filed Sep 8, 2025 (Schedule 13D/A).

Stake
8.20%
Shares
6,346,194
Intent
Active
What changed
Stake changed
Filed together
5 holders

The filing in full

HolderStakeShares
Samsara BioCapital, L.P.7.30%5,674,916
Samsara BioCapital GP, LLC7.30%5,674,916
Samsara Opportunity Fund, L.P.0.80%588,235
Samsara Opportunity Fund GP, LLC0.80%588,235
Srinivas Akkaraju8.20%6,346,194

Source

View original at SEC

Related